Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-23
1993-09-28
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142375, 514319, 540607, 544159, 546206, 546226, A61K 31535, A61K 3155, C07D21116, C07D295192
Patent
active
052486737
ABSTRACT:
The present invention provides new thrombin inhibiting bisamidines derivatives, their pharmaceutically acceptable salts and hydrates, methods for their preparation, pharmaceutical composition, a process for their preparation, and use of the compounds in treatment of thrombosis, ischemia and stroke.
REFERENCES:
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4440933 (1984-04-01), Montzka
patent: 4537896 (1985-08-01), Cleason et al.
John E. Starrett, Jr., et al., J. Med. Chem., 32: 2204 (1989).
Bajusz, et al., Int. J. Pept. Protein Res., 12: 217-221 (1978).
Balasubramanian Neelakantan
Han William T.
Bristol-Myers Squibb Co.
Kaye Michelle A.
Ramsuer Robert W.
LandOfFree
Bisamidine derivatives as thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisamidine derivatives as thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisamidine derivatives as thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2190995